Grandway Suntrust Life Sciences

Grandway Suntrust (Beijing) Investment Management is a prominent Chinese private equity and venture capital firm that specializes in growth capital and late-stage investments within the healthcare, TMT, and consumer sectors. The firm is particularly active in the life sciences industry, having served as a key investor for several high-profile Chinese biotechnology companies including InnoCare Pharma, Abbisko Therapeutics, and Antengene. Grandway Suntrust focuses on identifying innovative companies with strong clinical potential and supporting their path toward initial public offerings and commercialization. By leveraging its deep expertise in the Chinese regulatory and financial landscape, the firm plays a significant role in the development of the domestic biopharmaceutical ecosystem.